Latest

Brain: Clear change in the share price target

Last week, Brain held a capital market day. There the new management presented their medium-term goals. You have a vision and a strategy to move Brain forward.

Many interesting product candidates are in the pipeline and are being developed. This could pay off in the medium term. However, this still requires more patience, as the analysts at Deutsche Bank determine. 2021 is likely to be a rather subdued year. There shouldn’t be a major product launch yet. This can be seen as a disappointment.

The analysts confirm their buy recommendation for the shares of Brain. The price target is reduced from EUR 24.00 to EUR 12.00.

The shares of Brain are quoted unchanged at 7.50 euros.
More about biotech stocks on 4investors: click here

At a glance – chart and news: Brain Biotechnology Research and Information Network AG

Related Articles

Back to top button